- Global Pharma News & Resources

Intra-Uterine Contraceptive Devices Market to Grasp Outstanding Growth of USD 6.00 Billion by 2029

Data Bridge Market Research conducted a recent market intelligence study, thoroughly analyzing the Intra-Uterine Contraceptive Devices Market. The newly published report employs an appealing layout that presents essential data using visually engaging tables, graphs, charts, and figures. Through the integration of these well-designed visual elements, the report strives to enhance the accuracy and precision of the information provided, enabling readers to grasp a comprehensive understanding of the subject matter.

The finest Intra-Uterine Contraceptive Devices market research report is the result of a proficient team working meticulously, utilizing their potential capabilities. The key research methodology employed by the DBMR team is data triangulation, which involves data mining, analysis of the impact of data variables on the market, and primary validation. This rigorous approach ensures that the report provides clients with absolute knowledge and valuable insights into the new regulatory environment that aligns with their organization’s requirements. The Intra-Uterine Contraceptive Devices report proves to be immensely beneficial for clients as it helps them identify new opportunities and key customers crucial for their business growth and increased revenue. Leveraging efficient technology, innovative applications, and expertise, this market research report is structured in a way that effectively manages large and complex market data tables.

Global intra-uterine contraceptive devices market was valued at USD 4.09 billion in 2021 and is expected to reach USD 6.00 billion by 2029, registering a CAGR of 4.70% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get a Sample Copy of The Intra-Uterine Contraceptive Devices Market report @

The report is generated based on various factors, including market type, organization size, on-premises availability, end-users organization type, and geographical coverage in regions such as North America, South America, Europe, Asia-Pacific, and the Middle East & Africa. The gathered data and information are presented concisely and comprehensibly in the Intra-Uterine Contraceptive Devices report, employing graphs, charts, or tables to facilitate better user understanding. Two other significant success factors of this Intra-Uterine Contraceptive Devices market report are the thorough market share analysis and key trend analysis, which further enhance its value and usefulness for clients seeking to make informed business decisions and stay ahead in the market.

Key Growth Drivers:

  • Rise in Awareness

The rise in awareness regarding the birth control measures and family planning across the globe acts as one of the major factors driving the growth of intra-uterine contraceptive devices market.

  • Initiatives by Government

The increase in the initiatives by several governments and non-profit organizations to promote the use of IUDs accelerate the market growth.

  • Affordable Care Act (ACA)

The repealing Affordable Care Act (ACA) in the United States encouraging large section of women to choose for long-acting reversible contraception (LARC) owing to the lack of access to abortion further influence the market.

The report outlines the involvement of key players, including:

Teva Pharmaceutical Industries Ltd. (Jerusalem), Bayer (Germany), EUROGINE (Spain), CooperSurgical Inc. (US), Pfizer Inc. (US), HLL Lifecare Limited (Thiruvananthapuram), OCON Medical Ltd. (Israel), Prosan International BV (Netherlands), Melbea Innovations (Hungary), Allergan, Merck & Co., Inc. (US), DKT International (US), Medisafe Distribution Inc. (Canada), Medicines360 (US), Pregna International Limited (India), and Egemen International (Turkey),  among others.

Know More about This Premium Research Report @

Key Market Segmentation


  • Hormonal Intrauterine Device
  • Copper Intrauterine Device

Product Type

  • Mirena
  • Skyla
  • Paragard
  • Essure
  • Levosert

End User

  • Hospitals
  • Gynecology Clinics
  • Community Health Care Centers

The Intra-Uterine Contraceptive Devices market report includes the following countries in different regions:

The regions mentioned above encompass a comprehensive coverage of key markets, offering a global perspective on the market landscape. Here’s an overview of the regions and the countries they include:

  1. North America: United States, Canada, and Mexico.
  2. Europe: Germany, France, United Kingdom, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and other European countries.
  3. Asia-Pacific (APAC): China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and other Asia-Pacific countries.
  4. Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates (U.A.E), South Africa, Egypt, Israel, and other countries in the Middle East and Africa region.
  5. South America: Brazil, Argentina, and other countries in South America.

Incorporating these regions into market research is crucial as they serve as significant economic and industrial hubs with diverse consumer markets. By including these regions in their analyses, businesses gain valuable insights into global trends, enabling them to make informed decisions and develop effective strategies. Understanding the market dynamics in these regions helps companies cater to the distinct demands and preferences of various regional markets, whether they plan to expand their operations or simply stay updated with the ever-changing global landscape. This approach ensures that businesses can adapt and tailor their products or services to meet the specific needs of each region, ultimately leading to a more successful and sustainable global presence.

North America dominates the intra-uterine contraceptive devices market because of the technological advancements in intrauterine contraceptive devices within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rise in awareness among the woman population in the region.


Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Get the Complete Table of Contents @

Browse More Reports:

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email –

Editor Details

  • Company:
    • The Wire Times
Last Updated: 24-Jul-2023